Brief: Basilea Pharmaceutica: Cresemba Sales In Asia Pacific Trigger Milestone Payment From Pfizer
June 17 (Reuters) - BASILEA PHARMACEUTICA AG BSLN.S :
* CRESEMBA® SALES IN ASIA PACIFIC REGION TRIGGER SALES
MILESTONE
PAYMENT TO BASILEA FROM PFIZER
* BASILEA PHARMACEUTICA AG - SALES OF ANTIFUNGAL CRESEMBA
BY ITS
LICENSE PARTNER PFIZER INC. IN ASIA PACIFIC REGION EXCEEDED
THRESHOLD TRIGGERING FIRST SALES MILESTONE PAYMENT FOR THIS
REGION OF USD 1.25 MILLION
Source text for Eikon: ID:nGNX5FPWxK
Further company coverage: BSLN.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments